Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL | MicrobiomeTrials← Back to trialsNCT05588128
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-03-21Est. Completion: 2026-12-31
Enrollment target: 350 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Anatomic Stage IV Breast Cancer AJCC v8Breast CarcinomaHER2-Negative Breast CarcinomaHormone Receptor-Positive Breast Carcinoma
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a me…
Fairbanks, United StatesEst. completion Jul 31, 2027
Metastatic Castration-resistant Prostate Cancer
The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abira…
Goodyear, United StatesEst. completion Jan 7, 2030
Prostate CancerProstate Adenocarcinoma
The purpose of this study is to see whether giving a lower (de-escalated) dose of radiation therapy to some parts of the…
Basking Ridge, United StatesEst. completion May 28, 2030